āĻšā§āĻŽSLN âĸ NASDAQ
add
Silence Therapeutics PLC - ADR
ā§Ģ.ā§¯ā§Ļ$
ā§Š āĻŽāĻžāĻ°ā§āĻ, ā§¨:ā§¨ā§Ļ:ā§Šā§Š PM GMT -ā§Ģ · USD · NASDAQ · āĻĄāĻŋāĻ¸āĻā§āĻ˛ā§āĻŽāĻžāĻ°
āĻ¸ā§āĻāĻāĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ āĻ¯ā§āĻā§āĻ¤āĻ°āĻžāĻˇā§āĻā§āĻ°-āĻ āĻ¤āĻžāĻ˛āĻŋāĻāĻžāĻā§āĻā§āĻ¤ āĻ¸āĻŋāĻāĻŋāĻāĻ°āĻŋāĻāĻŋ
āĻāĻžāĻ˛ āĻļā§āĻˇ āĻ¯ā§ āĻĻāĻžāĻŽā§ āĻāĻŋāĻ˛
ā§Ģ.ā§¯ā§Ž$
āĻ¸āĻžāĻ°āĻž āĻĻāĻŋāĻ¨ā§āĻ° āĻā§āĻ°ā§āĻĄāĻŋāĻā§ā§ āĻ¸ā§āĻāĻā§āĻ° āĻĻāĻžāĻŽā§āĻ° āĻāĻ āĻž āĻ¨āĻžāĻŽāĻžāĻ° āĻ°ā§āĻā§āĻ
ā§Ģ.ā§Ēā§¨$ - ā§Ģ.ā§¯ā§¯$
āĻ¸āĻžāĻ°āĻž āĻŦāĻāĻ°ā§āĻ° āĻ°ā§āĻā§āĻ
ā§§.ā§¯ā§$ - ā§.ā§ā§Ž$
āĻŽāĻžāĻ°ā§āĻā§āĻ āĻā§āĻ¯āĻžāĻĒ
ā§¨ā§Ŧ.ā§¯ā§¨Â āĻā§ USD
āĻāĻĄāĻŧ āĻāĻ˛āĻŋāĻāĻŽ
ā§¨.ā§§ā§Ŧ āĻ˛āĻž
P/E āĻ
āĻ¨ā§āĻĒāĻžāĻ¤
-
āĻ˛āĻā§āĻ¯āĻžāĻāĻļ āĻĒā§āĻ°āĻĻāĻžāĻ¨
-
āĻĒā§āĻ°āĻžāĻāĻŽāĻžāĻ°āĻŋ āĻāĻā§āĻ¸āĻā§āĻā§āĻ
NASDAQ
āĻāĻŦāĻ°ā§ āĻ°ā§ā§āĻā§
āĻĢāĻžāĻāĻ¨āĻžāĻ¨ā§āĻ¸āĻŋā§āĻžāĻ˛ āĻĒāĻžāĻ°āĻĢāĻ°ā§āĻŽā§āĻ¯āĻžāĻ¨ā§āĻ¸
āĻā§ā§āĻ° āĻ¸ā§āĻā§āĻāĻŽā§āĻ¨ā§āĻ
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ
| (GBP) | ā§¨ā§Ļā§¨ā§§info | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | ā§§.ā§¨ā§Ē āĻā§ | ā§§ā§¨ā§Ŧ.ā§Ģā§¯% |
āĻŦā§āĻ¯āĻŦāĻ¸āĻž āĻāĻžāĻ˛āĻžāĻ¨ā§āĻ° āĻāĻ°āĻ | ā§Ģ.ā§Ļā§ŽÂ āĻā§ | ā§Ģā§Ģ.ā§¨ā§% |
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§Š.ā§¯ā§Ē āĻā§ | -ā§¨ā§§.ā§Ļā§¯% |
āĻ¨ā§āĻ āĻĒā§āĻ°āĻĢāĻŋāĻ āĻŽāĻžāĻ°ā§āĻāĻŋāĻ¨ | -ā§Šā§§ā§.ā§Ēā§Ē | ā§Ēā§Ŧ.ā§Ģā§Ŧ% |
āĻļā§ā§āĻžāĻ° āĻĒā§āĻ°āĻ¤āĻŋ āĻāĻĒāĻžāĻ°ā§āĻāĻ¨ | â | â |
EBITDA | -ā§Ē.ā§Ģā§Ŧ āĻā§ | -ā§Ēā§¯.ā§Ēā§Ē% |
āĻĒā§āĻ°āĻ¯ā§āĻā§āĻ¯ āĻā§āĻ¯āĻžāĻā§āĻ¸ā§āĻ° āĻšāĻžāĻ° | ā§§ā§Ē.ā§Ļā§Ŧ% | â |
āĻŦā§āĻ¯āĻžāĻ˛ā§āĻ¨ā§āĻ¸ āĻļāĻŋāĻ
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
| (GBP) | ā§¨ā§Ļā§¨ā§§info | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻā§āĻ¯āĻžāĻļ āĻ āĻāĻŽ āĻ¸āĻŽā§ā§āĻ° āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ | ā§.ā§Šā§Ģ āĻā§ | ā§¯ā§Ŧ.ā§Šā§% |
āĻŽā§āĻ āĻ¸āĻŽā§āĻĒāĻĻ | ā§¯.ā§Ŧā§¨Â āĻā§ | ā§§ā§§.ā§Žā§¯% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Ž.ā§ā§Â āĻā§ | ā§§ā§Š.ā§¯ā§Ž% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§Žā§Ģ.ā§¨ā§Ŧ āĻ˛āĻž | â |
āĻāĻāĻāĻ¸ā§āĻā§āĻ¯āĻžāĻ¨ā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāĻ° | ā§¨.ā§¯ā§¯Â āĻā§ | â |
āĻĒā§āĻ°āĻžāĻāĻ¸ āĻā§ āĻŦā§āĻ āĻ°ā§āĻļāĻŋāĻ | ā§¨ā§§.ā§Šā§Ŧ | â |
āĻ¸āĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | -ā§Šā§§.ā§Ēā§Ē% | â |
āĻŽā§āĻ˛āĻ§āĻ¨ āĻĨā§āĻā§ āĻā§ | -ā§Šā§§ā§.ā§Ļā§Ē% | â |
āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨
| (GBP) | ā§¨ā§Ļā§¨ā§§info | Y/Y āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ |
|---|---|---|
āĻ¨ā§āĻ āĻāĻ¨āĻāĻžāĻŽ | -ā§Š.ā§¯ā§Ē āĻā§ | -ā§¨ā§§.ā§Ļā§¯% |
āĻ
āĻĒāĻžāĻ°ā§āĻļāĻ¨ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āĻ¯āĻžāĻļ | ā§Ŧā§Ž.ā§Ļā§Ŧ āĻ˛āĻž | ā§§ā§Ŧā§Š.ā§§ā§Ŧ% |
āĻŦāĻŋāĻ¨āĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§Žā§Ŧ.ā§ā§Ŧ āĻ˛āĻž | -ā§¯.ā§ā§¯% |
āĻĢāĻžāĻāĻ¨ā§āĻ¯āĻžāĻ¨ā§āĻ¸āĻŋāĻ āĻĨā§āĻā§ āĻĒā§āĻ°āĻžāĻĒā§āĻ¤ āĻā§āĻ¯āĻžāĻļ | ā§Š.ā§Ļā§Â āĻā§ | ā§¯ā§¯.ā§Ļā§Ŧ% |
āĻ¨āĻāĻĻā§ āĻŽā§āĻ āĻĒāĻ°āĻŋāĻŦāĻ°ā§āĻ¤āĻ¨ | ā§Ē.ā§Ŧā§§Â āĻā§ | ā§¨ā§Šā§Ļ.ā§ā§Ŧ% |
āĻĢā§āĻ°āĻŋ āĻā§āĻ¯āĻžāĻļ āĻĢā§āĻ˛ā§ | -ā§Ēā§¯.ā§Ŧā§Ē āĻ˛āĻž | ā§Žā§Ģ.ā§Ēā§Ŧ% |
āĻ¸āĻŽā§āĻĒāĻ°ā§āĻā§
Silence Therapeutics is a London-based pharmaceutical company formed in 1994. The company has pioneered the development of short-interfering ribonucleic acid therapeutics for the treatment of rare diseases. Silence Therapeutics has offices in London, New Jersey, and Berlin, with its corporate headquarters located in Hammersmith, London. Wikipedia
āĻ¸āĻŋāĻāĻ
āĻ¸ā§āĻĨāĻžāĻĒāĻŋāĻ¤ āĻšā§ā§āĻā§
ā§§ā§¯ā§¯ā§Ē
āĻā§ā§āĻŦāĻ¸āĻžāĻāĻ
āĻāĻ°ā§āĻŽāĻāĻžāĻ°ā§
ā§§ā§§ā§Ŧ
